METOPIRONE 250

Country: Իսրայել

language: անգլերեն

source: Ministry of Health

active_ingredient:

METYRAPONE 250 MG

MAH:

CTS LTD

ATC_code:

V04CD01

pharmaceutical_form:

CAPSULES

administration_route:

PER OS

manufactured_by:

LABORATOIRE HRA PHARMA , FRANCE

therapeutic_group:

METYRAPONE

therapeutic_indication:

Diagnostic test of secondary adrenocortical insufficiency, treatment of resistant edema associated with increased aldosterone secretion.

authorization_date:

2010-06-01